We provide full-service Phase I clinical trial execution with a strong focus on safety, data quality, and regulatory compliance. Our early-phase unit supports first-in-human and advanced Phase I designs in healthy volunteers and selected patient populations. Studies are conducted in a controlled clinical environment with continuous medical oversight. We combine experienced investigators, efficient recruitment, and robust operational processes to ensure reliable early clinical data that supports confident decision-making in drug development.
Ethics Committee approval for all studies
Medical supervision by experienced clinical staff
Clear participant information and informed consent
Conducted in compliance with ICH-GCP and EU regulations
